Atlas FDA

Dimension CREA (Creatinine) and Dimension Vista CREA (Creatinine); The CREA method used on the Dimension clinical chemis

FDA device recall Z-2741-2015 · posted 2015-09-05 · Terminated

Recall details

Recalling firm
Siemens Healthcare Diagnostics, Inc.
Reason for recall
Siemens has confirmed that the Dimension CREA and Dimension Vista CREA may produce falsely depressed results up to - 12.7% and -22% respectively, for a creatinine concentration of 1.5 mg/dL when hemolysis exceeds 200 mg/dL and 300 mg/dL respectively.
Action taken
Siemens sent an Urgent Medical Device Correction letter, dated July 2015, was provided to all Dimension CREA and Dimension Vista CREA customers who received the products to notify them of the issue, the potential risk to health, and actions to be taken by customers. If you have any questions please contact your Siemens Customer Care Center Technical Solutions at (800) 441-9250, or your local Siemens Technical Support Representative.
Root cause
Device Design
Status
Terminated
Product code
JFY
Quantity affected
Total number Dimension Vista - 32,165, Dimension - 238,634
Distribution
Worldwide Distribution - US (nationwide) and to the countries of : Afghanistan, Algeria, Argentina, Armenia, Australia, Austria, Bahamas, Bahrain, Bangladesh, Belgium, Bolivia, Bosnia Herzegovinia, Bu
Date initiated
2015-07-15
Date posted
2015-09-05
Date terminated
2017-03-24
Location
Newark, DE

Monitor recalls programmatically

Recalls and clearances share one API, with change alerts when new recalls post.

Related 510(k) clearances

RecordFirmDate
DIMENSION VISTA CARBON DIOXIDE, CREATININE AND LACTATE DEHYDROGENASE FLEX REAGENT CARTRIDGE (K061238)Dade Behring, Inc.2006-05-25
CREATININE METH FOR USE ON THE DIMENSION CLIN CHEM (K925668)E.I. Dupont DE Nemours & Co., Inc.1992-12-28